港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

来凯医药-B

16.240

-0.420-2.52%

成交量：908.60万

成交额：1.49亿

市值：66.26亿

市盈率：-20.96

高：17.390

开：17.000

低：15.900

收：16.660

52周最高：23.500

52周最低：4.200

股本：4.08亿

香港流通股本：4.08亿

量比：3.03

换手率：2.23%

股息：- -

股息率：- -

每股收益(LYR):-0.775

净资产收益率：-34.59%

总资产收益率：-19.92%

市净率：8.53

市盈率(LYR):-20.96

市销率: 1314.13

数据加载中...

总览公司新闻公告

来凯医药-B05月28日遭主力抛售287.3万元

针对肥胖症治疗来凯医药（2105.HK）宣布LAE102美国I期临床试验完成首位受试者给药

来凯医药-B05月27日遭主力抛售167.0万元

来凯(2105.HK)将在2025美国糖尿病协会年会上展示多项ActRII领域自主研发成果

格隆汇资讯

来凯医药已与礼来达成合作，双巨头重新定义减肥医美

生物科技馆

来凯医药-B盘中异动股价大涨6.53%

生物医药股普遍上涨博安生物(06955)涨8.18%

来凯医药-B盘中异动早盘急速拉升5.73%

来凯医药-B05月21日获主力加仓1102.3万元

港股异动 | 来凯医药-B(02105)再涨超15% 公司已与礼来达成合作联合开发LAE102

来凯医药再涨超15%公司已与礼来达成合作联合开发LAE102

【热门行业】港股医药股集体走强创新出海驱动估值重构

医药股早盘继续走强来凯医药-B涨逾13%康宁杰瑞制药-B涨逾11%

港股异动 | 医药股早盘继续走强国内创新药出海势头强劲恒瑞医药即将登陆港股

创新药继续强势来凯医药(02105)涨超16% 机构指国产创新药技术与产品被MNC认可的确定性持续增强

【港股异动丨来凯医药大涨近18%，创年内新高】来凯医药-B(2105.HK)盘初拉升，一度涨近18%，报17.7港元，股价创去年11月底以来新高。

港股生物医药股延续昨日强势，来凯医药-B涨超14%

老虎资讯综合

来凯医药-B盘中异动早盘股价大涨5.06%报15.780港元

来凯医药-B05月20日主力净流入1207.2万元散户资金抛售

来凯医药-B盘中异动股价大涨5.20%报14.980港元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02105/news?page=6"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"来凯医药-B","latestPrice":16.24,"timestamp":1756195699001,"preClose":16.66,"halted":0,"volume":9086000,"delay":0,"floatShares":408000000,"shares":408000000,"eps":-0.7748513922001355,"marketStatus":"已收盘","change":-0.42,"latestTime":"08-26 16:08:19","open":17,"high":17.39,"low":15.9,"amount":148510298,"amplitude":0.089436,"askPrice":16.24,"askSize":268000,"bidPrice":16.2,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.7126478245693385,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756258200000},"marketStatusCode":5,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":16.66,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":3.025278,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":408000000,"roa":"-19.92%","roe":"-34.59%","lyrEps":-0.774851,"volumeRatio":3.025278,"shares":408000000,"dividePrice":0,"high":17.39,"amplitude":0.089436,"preClose":16.66,"low":15.9,"week52Low":4.2,"pbRate":"8.53","psRate":"1314.13","week52High":23.5,"institutionHeld":0,"latestPrice":16.24,"committee":-0.988868,"eps":-0.7748513922001355,"divideRate":0,"volume":9086000,"delay":0,"ttmEps":-0.7126478245693385,"open":17,"prevYearClose":9.37,"prevWeekClose":17.19,"prevMonthClose":18.8,"prevQuarterClose":17.46,"fiveDayClose":17.98,"twentyDayClose":19.98,"sixtyDayClose":19.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2025-08-13","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755048600000,"name":null,"time":"","dateTimestamp":1755014400000,"actualEps":null},{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"盘后","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1754496000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2025-08-25","current":-24.093478,"percent":0.08818,"low":-30.832985,"twenty":-16.858738,"median":-8.407124,"eighty":-4.826315,"high":-1.640852,"avg":-10.791117,"sd":7.187702,"marketCap":6322695243},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466},{"date":"2025-04-25","current":-18.85387,"twenty":-11.890039,"median":-7.064143,"eighty":-4.482534,"marketCap":5103616142},{"date":"2025-05-02","current":-20.273816,"twenty":-12.024603,"median":-7.138152,"eighty":-4.483904,"marketCap":5499650777},{"date":"2025-05-09","current":-20.37867,"twenty":-12.272607,"median":-7.171338,"eighty":-4.537135,"marketCap":5566901942},{"date":"2025-05-16","current":-19.209634,"twenty":-12.535336,"median":-7.205238,"eighty":-4.575802,"marketCap":5290424932},{"date":"2025-05-23","current":-24.021586,"twenty":-12.71305,"median":-7.273665,"eighty":-4.590948,"marketCap":6635448220},{"date":"2025-05-30","current":-24.266566,"twenty":-12.811921,"median":-7.298393,"eighty":-4.611692,"marketCap":6732588791},{"date":"2025-06-06","current":-26.139049,"twenty":-13.04892,"median":-7.396066,"eighty":-4.640938,"marketCap":7270598106},{"date":"2025-06-13","current":-29.74055,"twenty":-13.19671,"median":-7.470293,"eighty":-4.681154,"marketCap":8275629397},{"date":"2025-06-20","current":-28.050034,"twenty":-13.86335,"median":-7.533906,"eighty":-4.700982,"marketCap":7789926543},{"date":"2025-06-27","current":-24.148232,"twenty":-14.651862,"median":-7.597268,"eighty":-4.71884,"marketCap":6725116440},{"date":"2025-07-04","current":-23.234874,"twenty":-14.895898,"median":-7.634748,"eighty":-4.738772,"marketCap":6471056485},{"date":"2025-07-11","current":-22.291445,"twenty":-15.089879,"median":-7.696392,"eighty":-4.760215,"marketCap":6202051828},{"date":"2025-07-18","current":-26.31753,"twenty":-15.471722,"median":-7.782262,"eighty":-4.775945,"marketCap":7316474020},{"date":"2025-07-25","current":-25.476909,"twenty":-15.613487,"median":-7.864399,"eighty":-4.786942,"marketCap":7108532126},{"date":"2025-08-01","current":-24.329935,"twenty":-15.664049,"median":-8.108989,"eighty":-4.797184,"marketCap":6746559201},{"date":"2025-08-08","current":-25.903798,"twenty":-15.966112,"median":-8.199572,"eighty":-4.803824,"marketCap":7200950746},{"date":"2025-08-15","current":-26.404653,"twenty":-16.351868,"median":-8.297938,"eighty":-4.809409,"marketCap":6923694888},{"date":"2025-08-22","current":-24.957996,"twenty":-16.76437,"median":-8.37361,"eighty":-4.821672,"marketCap":6523837408},{"date":"2025-08-25","current":-24.093478,"twenty":-16.858738,"median":-8.407124,"eighty":-4.826315,"marketCap":6322695243}],"updateTime":1756186927627},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538429773","title":"来凯医药-B05月28日遭主力抛售287.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538429773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538429773?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 16:15","pubTimestamp":1748420153,"startTime":"0","endTime":"0","summary":"05月28日, 来凯医药-B股价跌2.66%，报收16.82元，成交金额4261.9万元，换手率0.62%，振幅6.37%，量比0.35。来凯医药-B今日主力资金净流出287.3万元，连续5日净流出，上一交易日主力净流出167.0万元。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为50.00%，平均跌幅为6.43%。该股近5个交易日下跌4.55%，主力资金累计净流出2821.9万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1120.4万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528173333a6f0261a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528173333a6f0261a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2538415499","title":"针对肥胖症治疗 来凯医药（2105.HK）宣布LAE102美国I期临床试验完成首位受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2538415499","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538415499?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 08:40","pubTimestamp":1748392849,"startTime":"0","endTime":"0","summary":"自主研发针对ActRIIA的单克隆抗体LAE102，在美国针对肥胖症治疗的一项I期临床试验已完成首位受试者给药。","market":"hk","thumbnail":"https://img3.gelonghui.com/1e106-80929f77-f573-4cd5-849b-71ff3a8ee7ae.jpg?guru_height=4016&guru_width=6024","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/1e106-80929f77-f573-4cd5-849b-71ff3a8ee7ae.jpg?guru_height=4016&guru_width=6024"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2242800","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1583","03347","BK1161","02105","BK1576","BK1141"],"gpt_icon":0},{"id":"2538457465","title":"来凯医药-B05月27日遭主力抛售167.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538457465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538457465?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 16:15","pubTimestamp":1748333745,"startTime":"0","endTime":"0","summary":"05月27日, 来凯医药-B股价跌0.80%，报收17.28元，成交金额9725.6万元，换手率1.36%，振幅6.54%，量比0.73。来凯医药-B今日主力资金净流出167.0万元，连续4日净流出，上一交易日主力净流出984.2万元。近一年数据显示，该股主力连续4日净流出后，次日下跌概率为75.00%，平均跌幅为4.27%。该股近5个交易日上涨15.45%，主力资金累计净流出1432.2万元；近20日主力资金累计净流出759.9万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527172750a48e2332&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527172750a48e2332&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2538548134","title":"来凯(2105.HK)将在2025美国糖尿病协会年会上展示多项ActRII领域自主研发成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2538548134","media":"格隆汇资讯","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538548134?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 08:45","pubTimestamp":1748306732,"startTime":"0","endTime":"0","summary":"2025年5月27日——来凯医药今日宣布，公司将在美国糖尿病协会第85届科学年会上，以壁报形式展示多项增肌减脂领域的研发成果——靶向ActRII的三款单克隆抗体LAE102、LAE103和LAE123的临床前数据，以及其中一款针对ActRIIA的单抗LAE102的首次人体研究数据。ADA科学年会是全球糖尿病领域的顶级学术盛会，将于今年6月20日-23日在美国芝加哥召开。LAE102是来凯医药自主研发的一种ActRIIA单克隆抗体，在临床前模型中已显示出增加肌肉并减少脂肪的效果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052708454997667ae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052708454997667ae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2538176383","title":"来凯医药已与礼来达成合作，双巨头重新定义减肥医美","url":"https://stock-news.laohu8.com/highlight/detail?id=2538176383","media":"生物科技馆","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538176383?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 11:36","pubTimestamp":1748230599,"startTime":"0","endTime":"0","summary":"近日，凯医药与礼来达成合。据悉，LAE102是来凯医药自主研发的全球首创ActRIIA单克隆抗体，旨在解决GLP-1受体激动剂减重疗法中常见的肌肉流失问题。来凯医药与礼来达成合作，联合开发LAE102，旨在加速其全球临床进程。2024年11月，来凯医药与礼来签订一项临床合作协议，旨在支持和加速LAE102针对肥胖症治疗的全球临床开发。礼来将负责在美国执行一项I期研究并承担相关费用。此次，来凯医药与礼来的战略合作，标志着生物制药与医美产业的深度融合。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526165335a6ed47e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526165335a6ed47e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","LLY","BK1161"],"gpt_icon":1},{"id":"2538142064","title":"来凯医药-B盘中异动 股价大涨6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538142064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538142064?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 09:32","pubTimestamp":1748223154,"startTime":"0","endTime":"0","summary":"2025年05月26日早盘09时32分，来凯医药-B股票出现波动，股价快速上涨6.53%。截至发稿，该股报18.920港元/股，成交量15.25万股，换手率0.04%，振幅5.52%。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，来凯医药-B、云康集团、圣诺医药-B涨幅较大，振幅较大的相关个股有巨子生物、来凯医药-B、歌礼制药-B，振幅分别为5.61%、5.52%、5.32%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052609323497655b04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052609323497655b04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2537742269","title":"生物医药股普遍上涨 博安生物(06955)涨8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537742269","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537742269?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:42","pubTimestamp":1747964552,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药股普遍上涨，博安生物 涨8.18%，来凯医药涨6.76%，亚盛医药涨5.74%，金斯瑞生物科技涨4.93%，和黄医药涨4.28%。万联证券指出，2025年国产创新药受益于政策、产业趋势等，估值迎来修复。“创新”是主旋律，在国际顶尖的创新药学术大会上，中国药企重要性越来越高。MNC目前很多公司核心的管线里均有来自中国的产品，国产创新药license-out金额和数量也创新高。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959181","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1141","BK1588","HK0000306701.USD","BK1191","BK1574","02105","01548","BK1161","06855","399441","161726","BK1587","00013","BK1576","HK0000320223.HKD","06955","HK0000320264.USD","HK0000306685.HKD"],"gpt_icon":0},{"id":"2537974545","title":"来凯医药-B盘中异动 早盘急速拉升5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537974545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537974545?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:34","pubTimestamp":1747964058,"startTime":"0","endTime":"0","summary":"2025年05月23日早盘09时34分，来凯医药-B股票出现异动，股价急速上涨5.73%。截至发稿，该股报18.460港元/股，成交量14.95万股，换手率0.04%，振幅9.85%。资金方面，该股资金流入184.905万港元，流出75.938万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，MIRXES-B、歌礼制药-B、来凯医药-B涨幅较大，振幅较大的相关个股有MIRXES-B、宜明昂科-B、来凯医药-B，振幅分别为12.66%、9.94%、9.85%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523093418aa2c9796&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523093418aa2c9796&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2537985207","title":"来凯医药-B05月21日获主力加仓1102.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537985207","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537985207?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 16:15","pubTimestamp":1747815343,"startTime":"0","endTime":"0","summary":"05月21日, 来凯医药-B股价涨17.18%，报收17.60元，成交金额2.8亿元，换手率3.99%，振幅17.84%，量比6.11。来凯医药-B今日主力资金净流入1102.3万元，上一交易日主力净流入1207.2万元。该股近5个交易日上涨27.17%，主力资金累计净流入1982.4万元；近20日主力资金累计净流入2796.8万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521172728a4869357&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521172728a4869357&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2537096366","title":"港股异动 | 来凯医药-B(02105)再涨超15% 公司已与礼来达成合作 联合开发LAE102","url":"https://stock-news.laohu8.com/highlight/detail?id=2537096366","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537096366?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 15:31","pubTimestamp":1747812713,"startTime":"0","endTime":"0","summary":"来凯医药与礼来达成合作，联合开发LAE102，旨在加速其全球临床进程。若LAE102能与GLP-1受体激动剂联合使用，有望成为解决减重治疗中肌肉流失问题的突破性方案，推动高质量体重管理领域的发展。据悉，LAE102是公司自主研发针对ActRIIA的单克隆抗体。阻断Activin-ActRII通路可促进肌肉再生和减少脂肪，这使LAE102成为实现优质体重控制的潜力候选药物。LAE103是ActRIIB选择性抗体，LAE123是针对ActRIIA/IIB双靶点抑制剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 来凯医药-B(02105)再涨超15% 公司已与礼来达成合作 联合开发LAE102","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2750360997.AUD","LU0109394709.USD","SG9999015945.SGD","BK4534","LU1551013342.USD","SGXZ51526630.SGD","BK4516","LU0238689110.USD","LU0882574055.USD","LU1974910355.USD","LU0456855351.SGD","LU1720051108.HKD","LU0114720955.EUR","02105","LU1804176565.USD","LU2552382215.SGD","IE00BK4W5L77.USD","LU2361044949.HKD","BK4581","LU1267930730.SGD","LU1720051017.SGD","LU2471134523.USD","LU0786609619.USD","LU2471134952.CNY","IE00BJT1NW94.SGD","BK4585","LU1280957306.USD","LU1064131342.USD","LU2237443895.HKD","LU2491050154.USD","LU1548497426.USD","LU1023059063.AUD","LU0471298694.HKD","SG9999014898.SGD","LU2237443465.HKD","LU2265009873.SGD","LU0094547139.USD","LU1035775433.USD","LU2023250504.SGD","LU2491050071.SGD","LU0256863902.USD","BK4533","LU0061475181.USD","BK4007","GB00BDT5M118.USD","IE00BK4W5M84.HKD","LU0097036916.USD","LU0122379950.USD","SG9999014906.USD"],"gpt_icon":1},{"id":"2537760196","title":"来凯医药再涨超15%公司已与礼来达成合作联合开发LAE102","url":"https://stock-news.laohu8.com/highlight/detail?id=2537760196","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537760196?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 15:31","pubTimestamp":1747812660,"startTime":"0","endTime":"0","summary":"来凯医药与礼来合作开发LAE102，旨在解决减重治疗中肌肉流失问题，推动体重管理发展，其股价涨幅超15%。公司已启动七项临床试验，专注于肥胖和肿瘤治疗。LAE102是自主研发的单克隆抗体，可促进肌肉再生和减少脂肪，具有优质体重控制潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052115461594fda85a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052115461594fda85a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161","LLY"],"gpt_icon":0},{"id":"2537082266","title":"【热门行业】港股医药股集体走强 创新出海驱动估值重构","url":"https://stock-news.laohu8.com/highlight/detail?id=2537082266","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537082266?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 14:03","pubTimestamp":1747807396,"startTime":"0","endTime":"0","summary":"2024年度业绩暨现金分红说明会上，恒瑞医药称其创新药出海成效显着，目前，公司已实现13项创新药海外授权，交易总额约为140亿美元。“出海”已成为中国医药企业的重要战略。今年4月中美关税摩擦以来，仍有多项药品出海BD交易达成，显示创新药出海势头仍然强劲。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250106/NDdkYmY2NGUzZGQ4YzY5MzkwZTM0MzQwMzk2Mjg3Mzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NDdkYmY2NGUzZGQ4YzY5MzkwZTM0MzQwMzk2Mjg3Mzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959053","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","02105","LU1226287792.SGD","LU1226287875.USD","01530","09606","BK1191","09969","LU1226287529.USD","IE00B031HY20.USD","01801","LU1993786604.SGD","LU1951186391.HKD","BK1583","BK1219","LU1152091754.HKD","LU0067412154.USD","BK1515","02561","LU1226288253.USD","SG9999004311.SGD","IE00B5MMRT66.SGD","BK1521","BK1500","BK1574","LU0588546209.SGD","SG9999004220.SGD","03692","BK1588","LU1152091168.USD","LU0880133367.SGD","LU1969619763.USD","02367","LU0072913022.USD","BK1207","BK1161","LU0501845795.SGD","IE00BZ08YR35.GBP","LU2328871848.SGD","159718","LU2488822045.USD","LU1807302812.USD","BK1589","LU1008478684.HKD","BK1593","02273","IE00BZ08YT58.USD","06160","IE00B543WZ88.USD","01093"],"gpt_icon":1},{"id":"2537679408","title":"医药股早盘继续走强 来凯医药-B涨逾13%康宁杰瑞制药-B涨逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537679408","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537679408?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 11:11","pubTimestamp":1747797060,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　医药股早盘继续强势，来凯医药-B（02105）上涨12.65%，报16.92港元；康宁杰瑞制药-B（09966）上涨10.91%，报8.44港元；亚盛医药-B（06855）上涨9.38%，报48.40港元；君实生物（01877）上涨8.16%，报16.96港元；昭衍新药（06127）上涨6.89%，报10.86港元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"81e47d774545ba217a24feab6560fced","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-05-21/doc-inexhwwf6151837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02105","159938","BK1161","09966","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"2537679157","title":"港股异动 | 医药股早盘继续走强 国内创新药出海势头强劲 恒瑞医药即将登陆港股","url":"https://stock-news.laohu8.com/highlight/detail?id=2537679157","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537679157?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 10:56","pubTimestamp":1747796176,"startTime":"0","endTime":"0","summary":"消息面上，三生制药与辉瑞达成60亿美元天价授权合作，创下中国创新药BD交易新纪录。国产创新药技术与产品被MNC认可的确定性持续增强，未来有望通过联合研发、利润分成等合作方式深度绑定。ADC、双抗、基因编辑等平台型技术已成为MNC争夺焦点，建议关注具备相关自主知识产权的药企。值得关注的是，恒瑞医药认购情况火热，截至认购结束， 孖展超购逾400倍。有分析认为，恒瑞医药的港股上市将成为医药板块的重要催化剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"81e47d774545ba217a24feab6560fced","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09966","BK0012","BK1161","BK1576","06127","HSCEI","LU0405327148.USD","LU2148510915.USD","LU1328615791.USD","BK1574","BK0239","BK0196","BK1141","LU1064131003.USD","01877","BK0188","YANG","09939","BK0060","06978","600276","BK0183","LU2328871848.SGD","BK1515","06855","BK0028","02105","LU2488822045.USD","BK4614","159992","159938","BK1583","LU1969619763.USD","LU0405327494.USD","LU1064130708.USD"],"gpt_icon":1},{"id":"2537128675","title":"创新药继续强势 来凯医药(02105)涨超16% 机构指国产创新药技术与产品被MNC认可的确定性持续增强","url":"https://stock-news.laohu8.com/highlight/detail?id=2537128675","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537128675?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 10:08","pubTimestamp":1747793302,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药延续昨日强势表现，来凯医药 涨16.38%，康希诺生物涨14.07%，君实生物涨8.93%，三康方生物涨5.95%，三叶草生物涨3.03%。万联证券报告指出，2025年国产创新药受益于政策、产业趋势等，估值迎来修复。“创新”是主旋律，在国际顶尖的创新药学术大会上，中国药企重要性越来越高。国产创新药技术与产品被MNC认可的确定性持续增强，未来有望通过联合研发、利润分成等合作方式深度绑定。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959030","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720050803.USD","02197","06185","IE00BPRC5H50.USD","BK1191","IE00B543WZ88.USD","LU0348784397.USD","159992","BK1161","BK1574","BK1583","01877","IE00B5MMRT66.SGD","02105","09926","LU0417516571.SGD","06978","LU2488822045.USD","LU0348783233.USD","LU1794554557.SGD","BK1515"],"gpt_icon":0},{"id":"2537673031","title":"【港股异动丨来凯医药大涨近18%，创年内新高】来凯医药-B(2105.HK)盘初拉升，一度涨近18%，报17.7港元，股价创去年11月底以来新高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537673031","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537673031?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 09:57","pubTimestamp":1747792679,"startTime":"0","endTime":"0","summary":"来凯医药-B(2105.HK)盘初拉升，一度涨近18%，报17.7港元，股价创去年11月底以来新高。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/21095750554176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1184183225","title":"港股生物医药股延续昨日强势，来凯医药-B涨超14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184183225","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184183225?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 09:51","pubTimestamp":1747792263,"startTime":"0","endTime":"0","summary":"港股异动｜生物医药股延续昨日强势，$来凯医药-B(02105)$涨超14%，$康希诺生物(06185)$涨近12%，$君实生物(01877)$涨超9%，$亚盛医药-B(06855)$、$百奥赛图-B(02315)$涨超7%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"305e35af160080a1ff409fd71b17ab9e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","07226","06855","HSCEI","BK1191","06185","HSTECH","YANG","02315","02105","BK1161","BK4614","BK1515"],"gpt_icon":0},{"id":"2537070678","title":"来凯医药-B盘中异动 早盘股价大涨5.06%报15.780港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537070678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537070678?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 09:33","pubTimestamp":1747791182,"startTime":"0","endTime":"0","summary":"2025年05月21日早盘09时33分，来凯医药-B股票出现异动，股价大幅上涨5.06%。截至发稿，该股报15.780港元/股，成交量9.95万股，换手率0.02%，振幅5.19%。资金方面，该股资金流入120.712万港元，流出10.088万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，百奥赛图-B、来凯医药-B、君实生物涨幅较大，振幅较大的相关个股有加科思-B、来凯医药-B、康希诺生物，振幅分别为5.21%、5.19%、4.43%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052109330294fd4a77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052109330294fd4a77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2536240613","title":"来凯医药-B05月20日主力净流入1207.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2536240613","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536240613?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 16:15","pubTimestamp":1747728933,"startTime":"0","endTime":"0","summary":"05月20日, 来凯医药-B股价涨5.48%，报收15.02元，成交金额9962.0万元，换手率1.63%，振幅7.02%，量比3.49。来凯医药-B今日主力资金净流入1207.2万元，上一交易日主力净流出199.0万元。该股近5个交易日上涨4.16%，主力资金累计净流入717.0万元；近20日主力资金累计净流入1720.8万元，其中净流入天数为10日。该股主力净额占比0.20%，港股市场排名43/2645。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520173707a485333e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520173707a485333e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2536657591","title":"来凯医药-B盘中异动 股价大涨5.20%报14.980港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536657591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536657591?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 09:32","pubTimestamp":1747704734,"startTime":"0","endTime":"0","summary":"2025年05月20日早盘09时32分，来凯医药-B股票出现异动，股价快速上涨5.20%。截至发稿，该股报14.980港元/股，成交量78.5万股，换手率0.19%，振幅5.62%。资金方面，该股资金流入1033.03万港元，流出92.365万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为1.44%。其相关个股中，华康生物医学、宜明昂科-B、基石药业-B涨幅较大，振幅较大的相关个股有华康生物医学、来凯医药-B、欧康维视生物-B，振幅分别为6.33%、5.62%、5.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520093214aa2c9348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520093214aa2c9348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":194,"code":"91000000","status":"200"}]}}